Correction of Hunter Syndrome in the MPSII Mouse Model by AAV2/8-Mediated Gene Delivery

被引：0
|
作者：
Cardone, Monica
Polito, Vinicia Assunta
Pepe, Stefano
Mann, Linda
D'Azzo, Alessandra
Auricchio, Alberto
Ballabio, Andrea
Cosma, Maria Pia
机构：
[1] TIGEM Telethon Inst Genet & Med, Naples, Italy
[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.234
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
209
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [21] Intravitreal AAV2 gene delivery to feline retinal ganglion cells
    Oikawa, Kazuya
    Eaton, J. Seth
    Kiland, Julie A.
    Torne, Odalys
    Mathu, Virginia
    Nickells, Robert W.
    McLellan, Gillian J.
    VISION RESEARCH, 2025, 226
  • [22] T-Lymphocyte Specific In Vivo Gene Delivery with CD8-Targeted AAV2 and AAV6
    Demircan, Muhammed Burak
    Zinser, Luca
    Michels, Alex
    Guaza-Lasheras, Mar
    John, Fabian
    Theuerkauf, Samuel Arthur
    Guenther, Dorothee
    Grimm, Dirk
    Chlanda, Petr
    Thalheimer, Frederic B.
    Buchholz, Christian J.
    MOLECULAR THERAPY, 2024, 32 (04) : 688 - 688
  • [23] RAPID CORRECTION OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY (OTCD) IN AN OTCD MOUSE MODEL USING A SELF-COMPLEMENTARY AAV2/8 VECTOR
    Jones, D. J.
    Wang, H.
    Bell, P.
    Avilan-Dorante, A.
    Gao, G.
    Batshaw, M. L.
    Wilson, J. M.
    Wang, L.
    Morizono, H.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 147 - 147
  • [24] Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero
    Lipshutz, GS
    Titre, D
    Brindle, M
    Bisconte, AR
    Contag, CH
    Gaensler, KML
    MOLECULAR THERAPY, 2003, 8 (01) : 90 - 98
  • [25] Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria
    Harding, CO
    Gillingham, MB
    Hamman, K
    Clark, H
    Goebel-Daghighi, E
    Bird, A
    Koeberl, DD
    GENE THERAPY, 2006, 13 (05) : 457 - 462
  • [26] Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria
    C O Harding
    M B Gillingham
    K Hamman
    H Clark
    E Goebel-Daghighi
    A Bird
    D D Koeberl
    Gene Therapy, 2006, 13 : 457 - 462
  • [27] Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho-/- mouse
    Palfi, Arpad
    Chadderton, Naomi
    O'Reilly, Mary
    Nagel-Wolfrum, Kerstin
    Wolfrum, Uwe
    Bennett, Jean
    Humphries, Peter
    Kenna, Paul
    Millington-Ward, Sophia
    Farrar, Jane
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2015, 2 : 15016
  • [28] Phenotypic Correction by AAV8 Gene Therapy of a Mouse Model of Wilson Disease
    Greig, Jenny A.
    Nordin, Jayme M. L.
    Smith, Melanie K.
    Draper, Christine
    Zhu, Yanqing
    Bell, Peter
    Buza, Elizabeth L.
    Wilson, James M.
    MOLECULAR THERAPY, 2018, 26 (05) : 384 - 384
  • [29] GNE myopathy: Assessment of an adeno associated virus AAV2/8 based GNE gene delivery system
    Mitrani-Rosenbaum, S.
    Yakovlev, L.
    Cohen, M. Becker
    Rivni, O.
    Harazi, A.
    Noguchi, S.
    Nishino, I.
    Fellig, Y.
    Argov, Z.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 811 - 811
  • [30] AAV2/5-mediated NGF gene delivery protects septal cholinergic neurons following axotomy
    Wu, K
    Meyer, EM
    Bennett, JA
    Meyers, CA
    Hughes, JA
    King, MA
    BRAIN RESEARCH, 2005, 1061 (02) : 107 - 113
12345